Argenx Nv Adr Stock Today
| ARGX Stock | USD 358.41 7.79 2.13% |
Performance0 of 100
| Odds Of DistressLess than 46
|
Argenx NV is trading at 358.41 as of the 19th of April 2024; that is -2.13 percent down since the beginning of the trading day. The stock's open price was 366.2. Argenx NV has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for argenx NV ADR are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 18th of May 2017 | Category Healthcare | Classification Health Care |
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Ltd, Universit Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, AgomAb Therapeutics NV, Broteio Pharma B.V., University of Texas, BioWa, Inc., Cilag GmbH International, Staten Biotechnology B.V., and Shire International GmbH. The company has 59.43 M outstanding shares of which 1.2 M shares are presently shorted by private and institutional investors with about 4.68 trading days to cover. More on argenx NV ADR
Follow Valuation Options Odds of Bankruptcy
Financial Report 2nd of May 2024
Argenx Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Argenx NV's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Argenx NV or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Tim Hauwermeiren | |||||||||||||||||||||||||||||||||||||||||||||
| Thematic Idea | Cancer Fighters (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Biotechnology, ARCA Biotechnology, NASDAQ Composite, NASDAQ Health Care, BEL All Share, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Argenx NV report their recommendations after researching Argenx NV's financial statements, talking to executives and customers, or listening in on Argenx NV's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering argenx NV ADR. The Argenx consensus assessment is calculated by taking the average forecast from all of the analysts covering Argenx NV. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Argenx NV's liquidity, profitability, solvency, and operating efficiency, argenx NV ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of argenx NV ADR is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Argenx NV's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Argenx NV's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Argenx NV's financial leverage. It provides some insight into what part of Argenx NV's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
argenx NV ADR (ARGX) is traded on NASDAQ Exchange in USA. It is located in Laarderhoogtweg 25, Amsterdam, Netherlands, 1101EB and employs 1,148 people. Argenx NV is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 21.6 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Argenx NV's market, we take the total number of its shares issued and multiply it by Argenx NV's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. argenx NV ADR conducts business under Biotechnology sector and is part of Health Care industry. The entity has 59.43 M outstanding shares of which 1.2 M shares are presently shorted by private and institutional investors with about 4.68 trading days to cover.
argenx NV ADR currently holds about 2.6 B in cash with (420.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 47.17.
Check Argenx NV Probability Of Bankruptcy
Ownership Allocationargenx NV ADR retains a total of 59.43 Million outstanding shares. Over half of Argenx NV's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Argenx NV. Please watch out for any change in the institutional holdings of argenx NV ADR as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Argenx Ownership Details
Argenx Stock Price Odds Analysis
Based on a normal probability distribution, the odds of Argenx NV jumping above the current price in 90 days from now is about 98.0%. The argenx NV ADR probability density function shows the probability of Argenx NV stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Argenx NV has a beta of 0.6707. This suggests as returns on the market go up, Argenx NV average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding argenx NV ADR will be expected to be much smaller as well. Additionally, argenx NV ADR has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Argenx NV to move above the current price in 90 days from now is about 98.0 (This argenx NV ADR probability density function shows the probability of Argenx Stock to fall within a particular range of prices over 90 days) .
Argenx Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Argenx NV that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Argenx NV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Argenx NV's value.| Instituion | Recorded On | Shares | |
| Massachusetts Financial Services Company | 2023-12-31 | 591.7 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 504.7 K | |
| Clearbridge Advisors, Llc | 2023-12-31 | 436.8 K | |
| Amvescap Plc. | 2023-12-31 | 436.2 K | |
| Citadel Advisors Llc | 2023-09-30 | 436.1 K | |
| Paradigm Biocapital Advisors Lp | 2023-12-31 | 422.6 K | |
| Holocene Advisors, Lp | 2023-09-30 | 372.2 K | |
| Federated Hermes Inc | 2023-12-31 | 356.5 K | |
| Millennium Management Llc | 2023-12-31 | 345.4 K | |
| Fmr Inc | 2023-12-31 | 3.8 M | |
| T. Rowe Price Associates, Inc. | 2023-12-31 | 3.7 M |
Argenx NV Historical Income Statement
argenx NV ADR Income Statement is one of the three primary financial statements used for reporting Argenx's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of argenx NV ADR revenue and expense. Argenx NV Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Argenx NV's Net Interest Income is fairly stable compared to the past year. Interest Income is likely to rise to about 97.6 M in 2024, whereas Interest Expense is likely to drop slightly above 858.8 K in 2024. View More FundamentalsArgenx Stock Against Markets
Picking the right benchmark for Argenx NV stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Argenx NV stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Argenx NV is critical whether you are bullish or bearish towards argenx NV ADR at a given time. Please also check how Argenx NV's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Argenx NV without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
Argenx NV Corporate Management
Elected by the shareholders, the Argenx NV's board of directors comprises two types of representatives: Argenx NV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Argenx. The board's role is to monitor Argenx NV's management team and ensure that shareholders' interests are well served. Argenx NV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Argenx NV's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Karen Massey | Chief Officer | Profile | |
| Torsten Dreier | Chief Development Officer | Profile | |
| Werner Lanthaler | Member of the Supervisory Board | Profile | |
| Beth DelGiacco | VP Relations | Profile | |
| Filip Borgions | VP Operations | Profile |
How to buy Argenx Stock?
Before investing in Argenx NV, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Argenx NV. To buy Argenx NV stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Argenx NV. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Argenx NV stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located argenx NV ADR stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased argenx NV ADR stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as argenx NV ADR, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Argenx Stock please use our How to Invest in Argenx NV guide.
Already Invested in argenx NV ADR?
The danger of trading argenx NV ADR is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Argenx NV is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Argenx NV. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile argenx NV ADR is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether argenx NV ADR offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Argenx NV's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Argenx Nv Adr Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Argenx Nv Adr Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in argenx NV ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the argenx NV ADR information on this page should be used as a complementary analysis to other Argenx NV's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Argenx Stock analysis
When running Argenx NV's price analysis, check to measure Argenx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Argenx NV is operating at the current time. Most of Argenx NV's value examination focuses on studying past and present price action to predict the probability of Argenx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Argenx NV's price. Additionally, you may evaluate how the addition of Argenx NV to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Argenx NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Argenx NV. If investors know Argenx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Argenx NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.16) | Revenue Per Share 0.8876 | Quarterly Revenue Growth 1.349 | Return On Assets (0.07) | Return On Equity (0.09) |
The market value of argenx NV ADR is measured differently than its book value, which is the value of Argenx that is recorded on the company's balance sheet. Investors also form their own opinion of Argenx NV's value that differs from its market value or its book value, called intrinsic value, which is Argenx NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Argenx NV's market value can be influenced by many factors that don't directly affect Argenx NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Argenx NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Argenx NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Argenx NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.